ALAS2 and X-linked lymphoproliferative disease: XLP, a less common condition, results from the genetically upregulated activity of the erythroid-specific aminolevulinic acid synthase (ALAS2, EC 2.3.1.27), the first enzyme of the heme-biosynthetic pathway in the erythroid cells [3].